Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs1764494 | chr13:37653007 | G/A | 0.000287 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1764495 | chr13:37652699 | G/T | 0.000287 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs17652568 | chr18:74591145 | T/C | 7.12E-9 | 174 | 25.77 | 24.3 | 10.17 | KM Plot |
PCPG | rs17677532 | chr17:50279497 | C/T | 6.66E-5 | 177 | 25.77 | 27.95 | 14.47 | KM Plot |
PCPG | rs17698291 | chr16:87329155 | T/A | 0 | 174 | 23.82 | 31.68 | 2.22 | KM Plot |
PCPG | rs17720657 | chr15:43377604 | C/T | 1.06E-9 | 178 | 25.87 | 24.7 | 13.35 | KM Plot |
PCPG | rs17747939 | chr7:66329634 | G/A | 0.000217 | 178 | 24.7 | 29.57 | 33.17 | KM Plot |
PCPG | rs17748121 | chr7:66399510 | C/T | 0.000206 | 177 | 24.7 | 28.42 | 33.17 | KM Plot |
PCPG | rs17748198 | chr7:66425626 | C/T | 0.000193 | 176 | 24.7 | 29.57 | 33.17 | KM Plot |
PCPG | rs17761155 | chr17:1433913 | A/G | 1.14E-5 | 178 | 24.7 | 26.73 | 25.17 | KM Plot |
PCPG | rs17782269 | chr14:74377761 | T/G | 1.16E-5 | 176 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs17782328 | chr14:74442857 | A/G | 0.000414 | 178 | 10.57 | 27.78 | 25.4 | KM Plot |
PCPG | rs17782387 | chr14:74584823 | G/A | 4.4E-7 | 177 | 25.4 | 27.78 | 7.4 | KM Plot |
PCPG | rs17784386 | chr16:89947457 | A/G | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs17788379 | chr3:195777211 | C/T | 1.72E-7 | 178 | 24.53 | 30.33 | 7.33 | KM Plot |